7Baggers
Quarterly
Annual
    Unit: USD2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-03-31 2018-06-30 2018-03-31 2017-09-30 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 
      
    		                                               
      cash flows from operating activities
    		                                               
      net income
    		-16,802,000 -95,930,000 -29,316,000 38,681,000 -17,359,000 -25,082,000 -62,857,000 -108,673,000 -615,024,000 41,314,000 -52,379,000 -35,958,000 -71,028,000 -312,640,000 -60,942,000 -34,936,000 -118,250,000 -64,000 643,000 -2,781,000 1,295,000 -3,002,000 -12,075,000 1,523,000 3,070,000 5,695,000 6,068,000 3,497,000 6,337,000 6,930,000 -232,611,000 10,571,000 11,844,000 10,841,000 -25,308,000 4,545,000 8,881,000 -161,316,000 9,053,000 8,215,000 10,867,000 10,265,000 9,576,000 8,924,000 8,444,000 7,184,000 6,864,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                               
      non-cash interest and leasing arrangements
    		6,695,000 6,424,000 6,023,000 5,901,000 6,117,000 5,222,000 16,138,000 22,878,000 18,827,000  22,589,000 22,650,000 24,989,000 24,275,000 21,920,000 24,192,000 23,413,000                               
      other non-cash gain
    		-19,834,000 -53,507,000 -44,100,000 -84,832,000 -1,364,000                                           
      share based compensation
    		   1,894,000 1,596,000 2,087,000 2,130,000 2,427,000 2,439,000  3,579,000 1,590,000 1,590,000 620,000 1,949,000 530,000 25,373,000                               
      depreciation and amortization expense
    		23,656,000 24,373,000 33,816,000 25,988,000 21,764,000 38,195,000                                          
      reduction in the carrying amount of operating lease right-of-use assets
    		   31,506,000                                            
      recovery for losses on accounts receivable
    		-523,000                                               
      equity in net income of unconsolidated affiliates
    		-1,358,000 -3,362,000 -3,576,000 127,000     -69,000  -893,000 -497,000 -763,000  -640,000                                 
      benefit for deferred taxes
    		-293,000 3,051,000 -422,000 -1,331,000 1,595,000 -835,000     -25,955,000 -417,000 4,415,000                                   
      loss (income) on early extinguishment of debt
    		                                               
      long-lived asset impairments
    		   9,700,000 0  27,257,000 28,360,000                                        
      changes in assets and liabilities:
    		                                               
      accounts receivable
    		13,347,000 6,193,000 98,650,000 7,321,000 -18,869,000 20,974,000 23,856,000 -870,000 -35,671,000  -33,305,000 -42,212,000 -60,866,000 -42,398,000 -23,531,000 -207,477,000 128,782,000 -13,268,000 -7,892,000 -7,538,000 -5,105,000 -5,968,000 12,509,000 -12,888,000 -8,149,000 -320,000 -2,172,000 -661,000 -12,140,000 2,509,000 -428,000 1,734,000 -13,114,000 -6,646,000 1,157,000 -4,984,000 -4,035,000 904,000 -1,629,000 -3,789,000 -11,322,000 -4,900,000 -5,658,000 9,607,000 -14,717,000 -14,123,000 -12,701,000 
      accounts payable and other accrued expenses and other
    		6,703,000 -19,806,000 24,374,000 7,277,000 -13,725,000 -18,759,000 -30,131,000 -10,026,000 15,069,000  4,373,000 -1,267,000 37,839,000 11,901,000 -5,277,000 -22,000,000 44,606,000                               
      medicare advance payments
    		                                               
      operating lease obligations
    		-24,891,000 -25,167,000 -27,610,000 -28,511,000 -26,999,000 -21,567,000                                          
      net cash from operating activities
    		34,573,000 -59,439,000 325,347,000 15,250,000 -22,924,000 12,146,000 17,556,000 -6,087,000 -1,769,000 33,059,000 11,787,000 -931,000 24,446,000 13,567,000 2,780,000   -5,138,000 10,245,000 15,477,000 5,737,000 11,089,000 23,043,000 9,308,000 4,481,000 11,740,000 16,816,000 15,142,000 -1,022,000 33,189,000 20,961,000 33,355,000 11,875,000 31,160,000 -34,373,000 20,373,000 18,138,000 29,490,000 16,631,000 20,812,000 7,964,000 20,340,000 15,967,000 24,670,000 2,036,000 16,240,000 6,547,000 
      cash flows from investing activities:
    		                                               
      capital expenditures
    		-13,576,000 -9,944,000 -10,818,000 -21,278,000 -15,681,000 -23,529,000 -10,690,000 -16,461,000 -14,624,000 -22,328,000 -22,893,000 -21,654,000 -26,243,000 -20,230,000 -28,635,000                                 
      free cash flows
    		20,997,000 -69,383,000 314,529,000 -6,028,000 -38,605,000 -11,383,000 6,866,000 -22,548,000 -16,393,000 10,731,000 -11,106,000 -22,585,000 -1,797,000 -6,663,000 -25,855,000                                 
      purchases of marketable securities
    		-24,795,000 -18,303,000 -23,828,000 -12,359,000 -22,420,000 -14,700,000 -24,034,000 -16,009,000 -6,354,000  -3,853,000 -21,070,000 -13,922,000 -56,397,000 -5,683,000                                 
      proceeds on maturity or sale of marketable securities
    		   19,416,000 14,449,000 8,257,000 17,383,000 15,702,000 30,998,000  6,740,000 32,809,000 13,465,000 21,611,000 2,280,000 7,265,000 10,158,000                               
      purchases of assets
    		   -9,146,000 0 -252,475,000         -1,895,000                                 
      sales of assets
    		40,878,000 10,791,000 46,437,000 161,408,000 20,174,000 79,000,000   -36,000  1,051,000    0 0 1,263,000                               
      restricted deposits
    		   749,000 -2,596,000      -2,253,000                                     
      investments in joint venture
    		   -14,886,000       76,000                                     
      loan provided to joint venture
    		0 0 0 -9,000,000                                            
      notes receivable and other investment additions
    		                                               
      other
    		1,653,000 -2,404,000 -245,000 32,000 -485,000 28,000 126,000 -1,099,000 -575,000  1,491,000 1,997,000 -366,000 484,000 1,695,000 -951,000 912,000                               
      net cash from investing activities
    		12,042,000 -192,176,000 31,666,000 114,936,000 6,031,000 -203,419,000 -17,215,000 -17,867,000 6,929,000  -37,862,000 -19,293,000 58,117,000 -185,551,000 -39,066,000 -35,157,000 6,290,000 -3,738,000 -2,886,000 -1,651,000 -3,550,000 9,484,000 -3,996,000 -3,580,000 -2,401,000 -7,009,000 -5,416,000 -3,625,000 -3,475,000 -15,204,000 -18,540,000 -3,656,000 -2,517,000 -7,864,000 -4,769,000 -54,074,000 -9,698,000 -15,336,000 -11,839,000 -7,297,000 -11,696,000 -14,731,000 -19,609,000 -25,248,000 -8,789,000 -10,468,000 -59,142,000 
      cash flows from financing activities:
    		                                               
      borrowings under revolving credit facilities
    		1,014,900,000 1,046,420,000 1,391,198,000 1,093,643,000 1,139,000,000 1,163,000,000 1,307,284,000 440,000,000                                        
      repayments under revolving credit facilities
    		-1,014,900,000 -1,046,420,000 -1,477,110,000 -1,143,692,000 -1,112,199,000 -1,194,676,000 -1,280,706,000 -445,749,000                                        
      proceeds from issuance of long-term debt
    		854,000 193,828,000 26,693,000 7,339,000 57,632,000 170,565,000 492,000 561,894,000 6,392,000  171,151,000 115,114,000 67,872,000 134,100,000 1,101,000 0 360,000,000     69,805,000    0 0                     
      repayment of long-term debt
    		-24,292,000 -25,997,000 -51,838,000 -89,654,000 -65,713,000 -4,467,000 -6,255,000 -451,169,000 -10,399,000  -172,990,000 -136,216,000 -127,717,000 -6,296,000 -9,527,000                                 
      repayment of finance lease obligations
    		   -712,000 -672,000 -575,000                                          
      debt issuance and settlement costs
    		                                               
      contributions from noncontrolling interests
    		544,000    0 18,500,000                                          
      distributions to noncontrolling interests and stockholders
    		-2,086,000 -1,334,000 -1,164,000 -1,123,000 -1,561,000 -1,138,000 -566,000 -15,000 -1,222,000  -357,000 -300,000 -240,000                                   
      net cash from financing activities
    		-30,933,000 183,777,000 -113,190,000 -134,439,000 14,630,000 147,501,000   -19,314,000 -21,741,000 33,237,000 14,698,000 -91,902,000 173,856,000 12,994,000 27,659,000 4,352,000 1,969,000 -4,783,000 -10,071,000 -2,159,000 -18,991,000 -18,471,000 -8,858,000 1,066,000 -5,927,000 -13,773,000 -15,826,000 -1,639,000 -18,410,000 -994,000 -15,624,000 -12,610,000  42,185,000 31,751,000 -9,861,000 -13,861,000 -14,121,000 -8,794,000 9,138,000 -7,889,000 4,256,000 299,000 5,733,000 -1,085,000 50,587,000 
      net increase in cash, cash equivalents and restricted cash and equivalents
    		15,682,000 -67,838,000   -2,263,000 -43,772,000 20,965,000 63,469,000                                        
      cash, cash equivalents and restricted cash and equivalents:
    		                                               
      beginning of period
    		0 0 0 125,806,000 0 142,276,000 0 58,638,000 0  0 0 61,543,000 0 0 0 87,548,000                               
      end of period
    		15,682,000 -67,838,000 243,823,000 121,553,000 -2,263,000 98,504,000 20,965,000 122,107,000 -14,154,000  7,162,000 -5,526,000 52,204,000 1,872,000 -23,292,000 -12,745,000 95,708,000                               
      supplemental cash flow information:
    		                                               
      interest paid
    		28,890,000 25,637,000 22,900,000 31,815,000 34,832,000 45,620,000 101,438,000 91,393,000 107,328,000  109,437,000 112,616,000 111,456,000 108,134,000 107,942,000 105,139,000 94,948,000                               
      net taxes paid
    		   1,430,000 -1,176,000 1,081,000 1,020,000 3,084,000                                        
      federal and state stimulus - covid-19 other income
    		                                               
      non-cash investing and financing activities:
    		                                               
      finance lease obligations, net write-down due to lease activity
    		84,000 55,000   472,000                                           
      assets subject to finance lease obligations, net write-down due to lease activity
    		-80,000 -29,000                                              
      operating lease obligations, net (write-down) gross-up due to lease activity
    		                                               
      assets subject to operating leases, net write-down (gross-up) due to lease activity
    		60,835,000 222,382,000                                              
      financing obligations, net write-down due to lease activity
    		    0                                           
      assets subject to financing obligations, net write-down due to lease activity
    		    0                                           
      debt issuance costs
    		 -3,165,000 -239,000 -240,000 -1,857,000 -3,708,000 -126,000 -16,552,000 -1,735,000  -7,615,000 -2,510,000 -2,316,000 -1,417,000 -1,000                                 
      federal stimulus - covid-19 other income
    		                                               
      provision (recovery) for losses on accounts receivable
    		  -161,000 201,000                                            
      loss on early extinguishment of debt
    		   1,328,000   0 9,300,000 0                                       
      net decrease in cash, cash equivalents and restricted cash and equivalents
    		   -4,253,000                                            
      finance lease obligations, net gross up (write-down) due to lease activity
    		   309,000                                            
      assets subject to finance lease obligations, net (gross-up) write-down due to lease activity
    		   -310,000 1,077,764,000                                           
      operating lease obligations, net gross-up due to lease activity
    		   -18,757,000 14,218,000 2,408,557,000                                          
      assets subject to operating leases, net (gross-up) due to lease activity
    		   14,320,000 -9,294,000 -2,264,702,000                                          
      (recovery) benefit from losses on accounts receivable
    		                                               
      goodwill and identifiable intangible asset impairments
    		                                               
      gain on early extinguishment of debt
    		                                               
      notes receivable and other investment reductions
    		                                               
      debt settlement costs
    		      501,000 -986,000                                        
      operating lease right-of-use asset amortization
    		     29,574,000                                          
      benefit from losses on accounts receivable
    		     -685,000  -1,524,000 25,187,000  25,602,000 29,681,000 26,493,000 31,692,000 23,320,000 22,117,000 23,392,000                               
      equity in net (income) loss of unconsolidated affiliates
    		     -61,000                                          
      (gain) loss on early extinguishment of debt
    		                                               
      other non-cash (gains) charges
    		     -16,917,000                                          
      finance lease obligations, net (write-down) gross-up due to lease activity
    		     -131,842,000                                          
      assets subject to finance lease obligations, net write-down (gross-up) due to lease activity
    		     61,512,000                                          
      financing obligations, net (write-down) gross-up due to lease activity
    		     -2,734,940,000                                          
      assets subject to financing obligations, net write-down (gross-up) due to lease activity
    		     1,718,507,000                                          
      customer receivership and other related charges
    		                                               
      proceeds from tenant improvement draws under lease arrangements
    		        0  48,000 610,000 499,000 887,000 1,938,000 0 95,000                               
      capital lease obligations, net (write-down) gross-up due to lease activity
    		                                               
      assets subject to capital lease obligations, net write-down (gross-up) due to lease activity
    		                                               
      equity in net income (income) of unconsolidated affiliates
    		      38,000 220,000                                        
      capital lease obligations and assets
    		                                               
      financing obligations
    		      -130,935,000 5,152,000 7,019,000  21,005,000 4,067,000 3,861,000 56,489,000 1,021,000 22,797,000 3,682,000                               
      financing obligation assets
    		                                               
      other non-cash charges
    		       68,000                                        
      depreciation and amortization
    		       51,503,000 59,390,000  61,104,000 67,953,000 61,765,000 61,576,000 62,494,000 53,616,000 60,077,000 5,994,000 6,120,000 6,035,000 6,085,000 6,226,000 6,130,000 6,047,000 6,219,000 6,276,000 6,258,000 6,591,000 6,275,000 6,193,000 6,459,000 6,432,000 6,145,000 6,806,000 6,305,000 5,992,000 5,944,000 5,950,000 6,014,000 5,867,000 5,477,000 5,444,000 5,301,000 5,073,000 5,160,000 5,068,000 4,419,000 
      benefit from deferred taxes
    		       250,000 1,997,000      -13,408,000                                 
      net cash provided (used in) by financing activities
    		       87,423,000                                        
      capital lease obligations
    		       -18,194,000                                        
      other non-cash charges and gains
    		        2,378,000  -5,174,000 -42,922,000 12,000 9,387,000 -3,105,000                                 
      customer receivership
    		        298,000                                       
      net change in restricted cash and equivalents
    		        -2,701,000  20,596,000 -8,190,000 8,578,000 22,572,000 -6,828,000                                 
      purchases of inpatient assets, net of cash acquired
    		          -38,817,000 -68,704,000 -778,000                                   
      borrowings under revolving credit facility
    		        127,000,000  195,000,000 243,000,000 224,000,000 275,000,000 223,000,000 220,000,000 146,500,000                               
      repayments under revolving credit facility
    		        -139,350,000  -152,000,000 -205,000,000 -254,000,000 -227,000,000 -201,000,000                                 
      net decrease in cash and cash equivalents
    		          7,162,000                                     
      cash and cash equivalents:
    		                                               
      net taxes refunded
    		        61,000                                       
      capital leases
    		        0  0   0 13,444,000                                 
      sale of investment in joint venture
    		          0 0 1,010,000    26,358,000                               
      net increase in cash and cash equivalents
    		            -9,339,000 1,872,000                                  
      consolidated statement of operations data:
    		                                               
      net revenues
    		                                               
      expenses
    		                                               
      income before income tax (benefit) expense
    		                                               
      income tax (benefit) expense
    		                                               
      income from continuing operations
    		                                               
      income from discontinued operations, net of taxes
    		                                               
      less net income (income) attributable to noncontrolling interests
    		                                               
      net income attributable to genesis healthcare, inc.
    		                                               
      loss per common share:
    		                                               
      weighted-average shares used for eps calculation
    		                                               
      basic
    		                                               
      diluted
    		                                               
      net income per common share attributable to genesis healthcare, inc.:
    		                                               
      other financial data:
    		                                               
      net cash from investing activities, net of capital expenditures
    		                                               
      balance sheet data:
    		                                               
      cash and cash equivalents
    		                                               
      working capital
    		                                               
      property and equipment and leased facility assets
    		                                               
      total assets
    		                                               
      long-term debt, including current installments
    		                                               
      capital lease obligations, including current installments
    		                                               
      financing obligations, including current installments
    		                                               
      stockholders' (deficit) equity
    		                                               
      net taxes (refunded) paid
    		          4,207,000 196,000 -14,180,000                                   
      non-cash financing activities:
    		                                               
      assumption of long-term debt
    		             0 111,000 110,166,000 326,610,000                               
      sales of inpatient assets
    		            76,373,000                                   
      long-lived asset impairment
    		                                               
      transaction costs
    		                                               
      issuance of stock
    		                                               
      taxes paid
    		             1,910,000 5,314,000 7,752,000 5,917,000                               
      sale of investment in joint ventures
    		              0                                 
      distributions to noncontrolling interests
    		              -2,517,000                                 
      cash and equivalents:
    		                                               
      cash flows from operating activities:
    		                                               
      total adjustments
    		                115,768,000                               
      purchase of marketable securities
    		                                               
      net increase in cash and equivalents
    		                8,160,000                               
      supplemental disclosure of cash flow information:
    		                                               
      deferred income taxes and other current assets
    		                42,533,000                               
      property, plant and equipment
    		                495,692,000                               
      change in fair value of contingent consideration
    		                 -476,000 7,000 -121,000 14,000 -1,620,000 79,000                         
      benefit from doubtful accounts
    		                 3,763,000 3,737,000 3,720,000 2,905,000 5,638,000 2,661,000 3,114,000 2,983,000 2,107,000 1,740,000 1,787,000 1,775,000 2,035,000 1,037,000 1,938,000 2,457,000 2,191,000 2,232,000 2,599,000 2,595,000 2,707,000 1,648,000 4,881,000 1,803,000 3,185,000 3,377,000 2,097,000 1,428,000 2,642,000 959,000 
      non-cash stock-based compensation
    		                 1,810,000 1,013,000 875,000 571,000 763,000 601,000 331,000 1,303,000 1,183,000 1,196,000 1,208,000 1,163,000 1,174,000 247,000 1,189,000 998,000 1,346,000 981,000 862,000 360,000 530,000 610,000 608,000 520,000 438,000 510,000 306,000 304,000 240,000 136,000 
      excess tax benefits from stock-based payment arrangements
    		                         0 0 0 242,000 54,000 0 -14,000 -295,000         0      
      gain on disposal of property and equipment
    		                                               
      amortization of deferred financing costs
    		                 742,000 723,000 903,000 900,000 768,000 779,000 685,000 638,000 640,000 530,000 818,000 825,000 851,000 826,000 825,000 826,000 825,000 923,000 723,000 1,421,000 1,422,000 1,421,000 1,074,000 794,000 793,000 794,000 795,000 686,000 636,000 583,000 
      deferred income taxes
    		                 -7,000 -899,000 -444,000 918,000 1,755,000 -6,364,000 3,603,000 477,000 2,475,000 1,384,000 -1,162,000 793,000 59,000 -21,262,000 40,000 10,077,000 3,333,000 -4,923,000 1,052,000 484,000 1,642,000 5,214,000 -779,000 -111,000 177,000 380,000 -432,000 -784,000 3,377,000 -808,000 
      amortization of discount on debt
    		                 134,000 134,000 141,000 141,000 186,000 235,000 237,000 238,000 318,000 156,000 288,000 144,000 168,000                  
      debt retirement costs
    		                         0 168,000                     
      impairment of long-lived assets
    		                             0                  
      changes in operating assets and liabilities:
    		                                               
      payments on notes receivable
    		                 449,000 446,000 220,000 507,000 1,009,000 885,000 642,000 777,000 817,000 817,000 739,000 743,000 -798,000 2,226,000 927,000 959,000 1,446,000 1,507,000 950,000 943,000 2,052,000 1,828,000         
      other current and non-current assets
    		                 -864,000 -764,000 4,280,000 -2,276,000 -3,558,000 -1,394,000 -31,000 -1,611,000 -2,037,000 1,257,000 284,000 -1,456,000 3,837,000 -4,587,000 9,212,000 -1,007,000 1,465,000 -8,349,000 -691,000 -597,000 3,983,000 -267,000 2,111,000 3,944,000 1,635,000 -437,000 1,304,000 -393,000   
      accounts payable and accrued liabilities
    		                 -585,000 7,053,000 6,969,000 -5,671,000 3,752,000 1,696,000 -1,207,000 1,973,000 -7,750,000 2,952,000 -4,027,000 -1,303,000 3,526,000 -766,000 1,215,000 -3,482,000 4,762,000 -10,082,000 4,217,000 2,799,000 4,890,000 -5,553,000 3,960,000 -5,509,000 7,108,000 -2,939,000 -5,244,000 1,998,000 18,083,000 4,218,000 
      employee compensation and benefits
    		                 -3,945,000 536,000 2,430,000 3,309,000 -4,154,000 -3,330,000 4,949,000 -5,277,000 4,060,000 -1,489,000 4,121,000 -5,609,000 4,781,000 329,000 1,604,000 -5,348,000 6,369,000 2,229,000 1,462,000 -879,000 -1,850,000 -730,000 289,000 694,000 -2,092,000 2,869,000 1,930,000 -2,352,000 3,420,000 3,961,000 
      insurance liability risks
    		                 943,000 -863,000 -419,000 2,231,000 809,000 2,678,000 2,065,000 2,206,000 -1,544,000 -90,000 -1,060,000 1,057,000 450,000 -884,000 -1,635,000 538,000 310,000 -2,090,000 -2,753,000 143,000 -1,783,000 -879,000 -1,939,000 667,000 -2,342,000 202,000 -193,000 1,843,000 -2,578,000 40,000 
      other long-term liabilities
    		                 495,000 162,000 298,000 -87,000 1,505,000 -1,858,000 1,311,000 -366,000 -203,000 -1,983,000 -1,094,000 132,000 1,279,000 -248,000 -838,000 847,000 -146,000 2,605,000 -1,672,000 52,000 356,000 493,000 288,000 53,000 650,000 1,879,000 476,000 392,000 -10,014,000 1,109,000 
      cash flows from investing activities
    		                                               
      additions to property and equipment
    		                 -3,738,000 -2,982,000 -2,711,000 -3,550,000 -3,459,000 -3,996,000 -3,580,000 -2,401,000 -7,009,000 -5,416,000 -3,622,000 -3,475,000 -5,182,000 -4,893,000 -3,656,000 -2,567,000 -4,575,000 -4,769,000 -8,694,000 -9,698,000 -11,973,000 -10,255,000 -8,499,000 -10,428,000 -15,156,000 -13,226,000 -12,311,000 -8,933,000 -9,000,000 -7,771,000 
      acquisitions
    		                         0 0                     
      proceeds from sale of property and equipment
    		                         0 0    0 0 400,000               
      proceeds from sale of investments
    		                                               
      proceeds from the sale of home health agency
    		                 0                              
      proceeds from the sale of land
    		                 0                              
      cash flows from financing activities
    		                                               
      borrowings under line of credit
    		                 74,000,000 67,500,000 78,500,000 78,500,000 109,499,000 89,083,000 76,000,000 89,000,000 72,500,000 72,000,000 149,000,000 13,500,000 0 21,500,000 11,000,000 55,500,000 19,500,000 52,500,000 54,500,000 48,000,000 78,000,000 -12,000,000 2,000,000 12,000,000 -5,000,000 6,000,000 2,000,000 10,000,000  48,000,000 
      repayments under line of credit
    		                 -68,000,000 -70,335,000 -85,000,000 -78,057,000 -87,942,000 -126,583,000 -77,000,000 -84,000,000 -73,000,000 -82,000,000 -103,500,000 -13,500,000 0 -21,500,000 -25,000,000 -67,500,000 -38,500,000 -8,500,000 -118,500,000 -55,000,000           
      repayments of long-term debt
    		                 -3,106,000 -1,759,000 -2,654,000 -2,087,000 -107,934,000 -57,934,000 -5,391,000 -3,730,000 -4,415,000 -3,514,000 -156,307,000 -1,187,000                   
      cash paid for financing costs
    		                                               
      proceeds from exercise of stock options
    		                 316,000 0                             
      taxes paid related to net share settlement of equity awards
    		                 -1,574,000 -3,000 -9,000 -334,000 -81,000 34,000 -18,000 -204,000 -3,000 -2,000 -19,000 -210,000 40,000 -59,000                 
      increase in cash and cash equivalents
    		                 -6,907,000 2,576,000 3,755,000 28,000 1,582,000 576,000 -3,130,000 3,146,000 -1,196,000 -2,373,000   -425,000 1,427,000   992,000 3,043,000 -1,950,000 -1,421,000 293,000 -8,939,000 4,721,000 5,406,000       
      cash and cash equivalents at beginning of period
    		                 0 0 0 4,177,000 0 0 0 2,003,000 0 0 0 16,017,000 0 0 0 4,192,000 0 0 0 3,528,000 0 0 0 2,047,000  0 0 5,012,000  0 
      cash and cash equivalents at end of period
    		                 -6,907,000 2,576,000 3,755,000 4,205,000 1,582,000 576,000 -3,130,000 5,149,000 -1,196,000 -2,373,000 -4,309,000 9,881,000 -425,000 1,427,000 14,075,000 940,000 992,000 3,043,000 -1,950,000 2,107,000 293,000 -8,939,000 4,721,000 7,453,000  614,000 -279,000 3,992,000  -2,008,000 
      loss on disposal of assets
    		                  68,000                             
      debt modification/retirement costs
    		                  21,000    432,000                         
      impairment of long lived assets
    		                  0                             
      proceeds from maturity of investments
    		                  0                             
      payment of financing costs
    		                  -186,000 -1,856,000 -181,000  -2,877,000                         
      exercise of stock options
    		                             0 0 0 26,000               
      disposal of fixed assets
    		                                  -1,708,000             
      acquisition of healthcare facilities and businesses, net of cash acquired
    		                             -10,372,000                  
      proceeds from divestitures
    		                                               
      (gain) loss on disposal of property and equipment
    		                                               
      cash paid for purchase of previously leased facilities
    		                                               
      disposal of property and equipment
    		                          24,000    0 3,000 290,000               
      additions to deferred financing costs
    		                          -257,000       0 214,000   0 0    0 0 -1,383,000  -319,000 
      acquisition of home health licenses
    		                              0 0 -350,000               
      decrease in cash and cash equivalents
    		                            -6,136,000    -3,252,000          614,000 -279,000 -1,020,000  -2,008,000 
      net income from continuing operations
    		                                 10,841,000 -25,308,000 4,545,000 8,881,000 -161,316,000          
      net income from discontinued operations
    		                                     0          
      tax benefit from reversal of accrual for uncertain tax positions
    		                                     -624,000          
      write-off of deferred financing costs
    		                                 0 0             
      proceeds from sale of land
    		                                               
      repayments of long-term debt and capital leases
    		                             -18,396,000 -935,000 -939,000 -931,000 -3,304,000 -2,029,000 -251,128,000 -2,861,000 -2,861,000 -2,121,000 -2,842,000 -2,862,000       
      issuance of debt
    		                                               
      cash flows from discontinued operations
    		                                     0          
      proceeds from issuance long-term debt
    		                                               
      amortization of discount and accretion on debt
    		                               152,000 140,000  148,000             
      acquisition of healthcare facilities and businesses
    		                                  0             
      (gain) loss on disposal of asset
    		                                               
      goodwill impairment charge
    		                                               
      acquistion of healthcare facilities and businesses
    		                                               
      proceeds from disposal of property and equipment
    		                                               
      fees paid for early extinguishment of debt
    		                                               
      change in the fair value of acquisition-related contingent consideration
    		                                               
      change in the fair value of acquistion-related contingent consideration
    		                                               
      loss on disposal of asset
    		                                     0 1,000 0 60,000       
      amortization of discount on senior subordinated notes
    		                                    27,000 27,000 27,000 26,000 27,000 27,000 26,000 27,000 27,000 27,000 31,000 
      change in other assets
    		                                               
      premium on redemption of debt and write-off of deferred financing costs
    		                                               
      change in fair value of interest rate hedge
    		                                             0 7,000 
      non-current income tax receivable
    		                                               
      acquisition of healthcare facilities
    		                                     -3,363,000 0   -308,000 -9,460,000   -1,210,000 -50,583,000 
      changes in other assets
    		                                        -1,604,000  315,000 -14,000 -344,000 -689,000 -1,247,000 
      cash distributed related to the onex transaction
    		                                             0 0 
      proceeds from ipo, net of expenses
    		                                               
      supplemental cash flow information
    		                                               
      cash paid for:
    		                                               
      interest expense, net of capitalized interest
    		                                       3,932,000 11,691,000  11,556,000     
      income taxes
    		                                       10,051,000 572,000 2,817,000 5,436,000     
      non-cash activities:
    		                                               
      conversion of accounts receivable into notes receivable
    		                                       4,950,000 5,307,000 0 0     
      change in notes receivable
    		                                        336,000       
      operating activities
    		                                               
      (gain) loss on sale of assets
    		                                               
      investing activities
    		                                               
      financing activities
    		                                               
      repayments on long-term debt and capital leases
    		                                         -2,889,000 -1,767,000 -1,701,000 -2,884,000 -2,060,000 2,894,000 
      additions to deferred financing costs of new debt
    		                                               
      proceeds from the issuance of new common stock
    		                                               
      cash and cash equivalents at beginning of year
    		                                               
      cash and cash equivalents at end of year
    		                                               
      interest, net of capitalized interest
    		                                               
      insurance premium financed
    		                                         -182,000      
      loss on sale of assets
    		                                               
      write-off of deferred financing costs and premium on early redemption of debt
    		                                              0 
      principal payments on notes receivable
    		                                               
      principal payments on (additions to) notes receivable
    		                                           669,000 488,000   
      reorganization expenses
    		                                               
      cumulative effect of a change in accounting principle
    		                                               
      gain on sale of assets
    		                                               
      forgiveness of stockholder loan
    		                                               
      other current assets
    		                                             2,684,000 -2,271,000 
      net cash paid for reorganization costs
    		                                               
      borrowings (repayments) under line of credit
    		                                               
      repayments on long-term debt through refinancing
    		                                               
      redemption of preferred stock
    		                                               
      purchase of treasury stock
    		                                               
      proceeds from exercise of warrants and cash settlement of stock options
    		                                               
      dividends paid
    		                                               
      proceeds from capital contributions related to the onex transaction
    		                                               
      proceeds from sale of interest rate hedge
    		                                               
      purchase of interest rate hedge
    		                                               
      supplemental disclosure of non-cash investing and financing activities:
    		                                               
      reclassification of accounts receivable to notes receivable
    		                                               
      loss on disposal of property and equipment
    		                                               
      (additions to) principal payments on notes receivable
    		                                               
      premium paid for redemption of debt
    		                                              0 
      proceeds from initial public offering of common stock, net of expenses
    		                                              12,000 
      (additions) principal payments on notes receivable
    		                                               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.